Elderly people with frailty, which affects up to one-quarter of over-50s, increased their endurance after a single dose of ...
A cancer drug class best known for attacking tumors may also help your immune system remember them better. Researchers at ...
Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells ...
In 2024, Professor Sebastian Kobold's research group at LMU University Hospital had already shown that the metabolite prostaglandin E2 can block T cells—the killer cells of the immune system—in the ...
CAR architecture has evolved through four generations. The first relied solely on CD3ζ and lacked potency. Second-generation receptors added either CD28 or 4-1BB costimulation, striking a balance ...
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...
A new study describes a technique that rejuvenates aging blood-forming stem cells and could help reduce the risk of age-related blood disorders.
A genetics‑guided drug, compound 6, targets CARD9 to subtly calm gut inflammation in Crohn’s disease, pointing to safer, longer‑lasting, precision treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results